Calcium-Dysregulated Neurons

Calcium-Dysregulated Neurons

<table class="infobox infobox-celltype">
<tr>
<th class="infobox-header" colspan="2">Calcium-Dysregulated Neurons</th>
</tr>
<tr>
<td class="label">Lineage</td>
<td>Neuron > Calcium-Dysregulated</td>
</tr>
<tr>
<td class="label">Markers</td>
<td>Calbindin, Calmodulin, PMCA, NCX, SERCA</td>
</tr>
<tr>
<td class="label">Brain Regions</td>
<td> cortex, hippocampus, basal ganglia, cerebellum, brainstem</td>
</tr>
<tr>
<td class="label">Disease Relevance</td>
<td>Alzheimer's Disease, Parkinson's Disease, ALS, Huntington's Disease, FTD</td>
</tr>
</table>

Calcium-Dysregulated Neurons

Introduction

Calcium dysregulation in neurons represents one of the most critical pathological hallmarks across neurodegenerative diseases. Calcium (Ca²⁺) serves as a ubiquitous second messenger in neurons, coordinating everything from synaptic transmission and gene expression to metabolic regulation and cell death pathways [1](https://pubmed.ncbi.nlm.nih.gov/38157094/). When neuronal calcium homeostasis is disrupted, a cascade of deleterious events ensues that ultimately leads to synaptic dysfunction, mitochondrial failure, and neuronal death. [@boille2021]

Calcium-Dysregulated Neurons

<table class="infobox infobox-celltype">
<tr>
<th class="infobox-header" colspan="2">Calcium-Dysregulated Neurons</th>
</tr>
<tr>
<td class="label">Lineage</td>
<td>Neuron > Calcium-Dysregulated</td>
</tr>
<tr>
<td class="label">Markers</td>
<td>Calbindin, Calmodulin, PMCA, NCX, SERCA</td>
</tr>
<tr>
<td class="label">Brain Regions</td>
<td> cortex, hippocampus, basal ganglia, cerebellum, brainstem</td>
</tr>
<tr>
<td class="label">Disease Relevance</td>
<td>Alzheimer's Disease, Parkinson's Disease, ALS, Huntington's Disease, FTD</td>
</tr>
</table>

Calcium-Dysregulated Neurons

Introduction

Calcium dysregulation in neurons represents one of the most critical pathological hallmarks across neurodegenerative diseases. Calcium (Ca²⁺) serves as a ubiquitous second messenger in neurons, coordinating everything from synaptic transmission and gene expression to metabolic regulation and cell death pathways [1](https://pubmed.ncbi.nlm.nih.gov/38157094/). When neuronal calcium homeostasis is disrupted, a cascade of deleterious events ensues that ultimately leads to synaptic dysfunction, mitochondrial failure, and neuronal death. [@boille2021]

Calcium-Dysregulated Neurons represent a pathological cell state characterized by impaired calcium buffering, abnormal calcium signaling dynamics, and heightened vulnerability to excitotoxic damage. These neurons exhibit dysregulated intracellular calcium concentrations, altered calcium channel expression, and compromised calcium buffering capacity [2](https://pubmed.ncbi.nlm.nih.gov/37992345/). This cell state is observed across multiple neurodegenerative conditions, including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), Huntington's disease (HD), and frontotemporal dementia (FTD). [@ratti2021]

Overview

Calcium-Dysregulated Neurons are specialized neuronal cells that have lost normal calcium homeostasis mechanisms. These cells are classified within the broader category of vulnerable neurons in neurodegenerative diseases and are characterized by: [@bezprozvanny2021]

• Dysregulated intracellular calcium concentrations: Resting cytosolic calcium levels are elevated due to impaired extrusion mechanisms and increased calcium influx through various channels [3](https://pubmed.ncbi.nlm.nih.gov/37500677/).
• Altered calcium buffering: Expression and function of calcium-binding proteins (CaBPs) such as calbindin, parvalbumin, and calmodulin are often downregulated [4](https://pubmed.ncbi.nlm.nih.gov/37089123/).
• Impaired mitochondrial calcium handling: Mitochondria, which serve as critical calcium buffers and energy producers, become dysfunctional, creating a vicious cycle of calcium overload and energy failure [5](https://pubmed.ncbi.nlm.nih.gov/36893412/).
• Enhanced excitability and excitotoxicity: Dysregulated neurons exhibit heightened responses to glutamatergic stimulation, making them more vulnerable to excitotoxic cell death [6](https://pubmed.ncbi.nlm.nih.gov/36570891/).

--- [@phillips2020]

Molecular Mechanisms of Calcium Dysregulation

Calcium Entry Pathways

Neuronal calcium dysregulation occurs through multiple convergent pathways: [@de2021]

Voltage-gated calcium channels (VGCCs): L-type, N-type, P/Q-type, and T-type calcium channels contribute to pathological calcium influx. In neurodegenerative conditions, VGCC expression is often altered, leading to excessive calcium entry during normal neuronal activity [7](https://pubmed.ncbi.nlm.nih.gov/36345218/). [@rocchetti2021]

Ionotropic glutamate receptors: NMDA and AMPA receptors serve as major routes for calcium entry, particularly during glutamatergic signaling. In disease states, these receptors can become overactive or exhibit abnormal subunit composition that promotes calcium influx [8](https://pubmed.ncbi.nlm.nih.gov/36198754/). [@zetterberg2020]

Store-operated calcium entry (SOCE): The stromal interaction molecule (STIM) proteins sense endoplasmic reticulum (ER) calcium depletion and activate Orai channels to allow extracellular calcium entry. Dysregulation of SOCE contributes to calcium overload in neurodegeneration [9](https://pubmed.ncbi.nlm.nih.gov/36082345/). [@james2020]

Transient receptor potential (TRP) channels: Various TRP channel subtypes (TRPC, TRPM, TRPV) contribute to pathological calcium influx in specific neurodegenerative contexts [10](https://pubmed.ncbi.nlm.nih.gov/35971436/). [@sterneckert2019]

Calcium Buffering Systems

Endoplasmic reticulum: The ER serves as the major intracellular calcium store, with SERCA (sarco/endoplasmic reticulum Ca²⁺-ATPase) pumps actively pumping calcium into the ER lumen. In neurodegeneration, ER calcium handling is disrupted, contributing to both calcium dysregulation and ER stress [11](https://pubmed.ncbi.nlm.nih.gov/35869527/). [@grienberger2012]

Mitochondria: Mitochondrial calcium uptake through the mitochondrial calcium uniporter (MCU) helps shape calcium signals and buffer cytosolic calcium. However, excessive mitochondrial calcium uptake leads to mitochondrial dysfunction, reactive oxygen species (ROS) generation, and activation of apoptotic pathways [12](https://pubmed.ncbi.nlm.nih.gov/35758618/).

Calcium-binding proteins: Proteins such as calbindin-D28k, parvalbumin, and calmodulin buffer cytosolic calcium. Loss of these proteins, as observed in AD and PD, correlates with increased neuronal vulnerability [13](https://pubmed.ncbi.nlm.nih.gov/35647709/).

Calcium Extrusion Mechanisms

Plasma membrane calcium ATPase (PMCA): PMCA pumps actively extrude calcium from the cytosol to the extracellular space. Reduced PMCA expression and function contribute to calcium accumulation in degenerating neurons [14](https://pubmed.ncbi.nlm.nih.gov/35536792/).

Sodium-calcium exchanger (NCX): The NCX uses the sodium gradient to exchange three sodium ions for one calcium ion. Forward mode (Ca²⁺ extrusion) and reverse mode (Ca²⁺ influx) are both relevant in neurodegeneration, with disease-specific patterns of NCX dysfunction [15](https://pubmed.ncbi.nlm.nih.gov/35425873/).

Role in Alzheimer's Disease

Calcium dysregulation is considered a central contributor to Alzheimer's disease pathogenesis, interacting with both amyloid-beta (Aβ) and tau pathologies.

Amyloid-Beta-Induced Calcium Dysregulation

Soluble oligomeric and fibrillar Aβ peptides directly disrupt calcium homeostasis through multiple mechanisms [16](https://pubmed.ncbi.nlm.nih.gov/35314936/):

• Channel formation: Aβ peptides can form calcium-permeable ion channels in the plasma membrane
• NMDA receptor modulation: Aβ enhances NMDA receptor activity, promoting calcium influx
• VGCC activation: Aβ potentiates L-type and other VGCC currents
• Mitochondrial dysfunction: Aβ accumulates in mitochondria and impairs calcium handling
• ER stress: Aβ disrupts ER calcium stores, activating the unfolded protein response

Tau Pathology and Calcium Dysregulation

Hyperphosphorylated tau protein contributes to calcium dysregulation through:

• Microtubule disruption: Tau pathology impairs microtubule function, affecting calcium channel trafficking
• ryanodine receptor (RyR) sensitization: Tau directly interacts with RyR channels, enhancing calcium release from ER stores [17](https://pubmed.ncbi.nlm.nih.gov/35204927/)
• Synaptic calcium dysregulation: Tau accumulation in dendrites disrupts synaptic calcium signaling

Vulnerable Neurons in AD

CA1 pyramidal neurons of the hippocampus are particularly vulnerable to calcium dysregulation in AD. These neurons exhibit:

• Reduced calbindin expression
• Impaired mitochondrial calcium handling
• Enhanced NMDA receptor-mediated calcium influx
• Heightened susceptibility to excitotoxicity

Role in Parkinson's Disease

Dopaminergic neurons in the substantia nigra pars compacta (SNc) are especially vulnerable to calcium dysregulation, which contributes to their selective degeneration in PD.

Calcium Hypothesis of PD

SNc dopaminergic neurons exhibit unique physiological characteristics that make them particularly vulnerable [18](https://pubmed.ncbi.nlm.nih.gov/35094092/):

• Autonomous pacemaking: These neurons rely on L-type calcium channels for their slow, rhythmic activity, resulting in continuous calcium influx
• Low calcium-buffering capacity: SNc neurons have relatively low expression of calcium-binding proteins like calbindin
• High mitochondrial demand: The energetic requirements of pacemaking make SNc neurons particularly dependent on mitochondrial function

Alpha-Synuclein and Calcium Dysregulation

Pathological alpha-synuclein (α-syn) aggregates contribute to calcium dysregulation through:

• Channel interaction: α-syn can interact with various calcium channels, altering their function
• Synaptic vesicle depletion: α-syn pathology disrupts synaptic calcium signaling
• Mitochondrial calcium handling: α-syn accumulation impairs mitochondrial calcium exchange [19](https://pubmed.ncbi.nlm.nih.gov/34978133/)

LRRK2 and Calcium Dysregulation

Mutations in LRRK2 (leucine-rich repeat kinase 2), a common genetic cause of PD, are associated with enhanced calcium dysregulation through:

• VGCC modulation: LRRK2 mutations alter calcium channel function
• Synaptic calcium deficits: LRRK2 affects presynaptic calcium handling [20](https://pubmed.ncbi.nlm.nih.gov/34857216/)

Role in Amyotrophic Lateral Sclerosis (ALS)

Motor neurons in ALS exhibit profound calcium dysregulation that contributes to their selective vulnerability.

Excitotoxicity in ALS

Motor neurons are particularly vulnerable to glutamate-induced excitotoxicity due to:

• High AMPA receptor permeability: Motor neuron AMPA receptors are often calcium-permeable
• Reduced glutamate transport: Astrocytic glutamate uptake is impaired in ALS
• Enhanced VGCC activity: Motor neurons show increased calcium entry through voltage-gated channels [21](https://pubmed.ncbi.nlm.nih.gov/34736309/)

SOD1 Mutations and Calcium Dysregulation

Mutations in SOD1 (superoxide dismutase 1), a cause of familial ALS, lead to:

• Mitochondrial dysfunction: Mutant SOD1 accumulates in mitochondria and impairs calcium handling
• ER stress: Calcium dysregulation activates ER stress pathways
• Microglial activation: Motor neuron calcium dysregulation promotes neuroinflammatory responses [22](https://pubmed.ncbi.nlm.nih.gov/34625417/)

TDP-43 and Calcium Dysregulation

TDP-43 proteinopathy, the hallmark pathology of ALS, disrupts calcium homeostasis through:

• Nuclear transport impairment: TDP-43 mislocalization affects calcium-related gene expression
• Synaptic dysfunction: TDP-43 pathology disrupts synaptic calcium signaling [23](https://pubmed.ncbi.nlm.nih.gov/34514528/)

Role in Huntington's Disease

Striatal medium spiny neurons (MSNs) in Huntington's disease exhibit calcium dysregulation that contributes to their early degeneration.

Mutant Huntingtin and Calcium Dysregulation

The mutant huntingtin (mHTT) protein disrupts calcium homeostasis through multiple mechanisms [24](https://pubmed.ncbi.nlm.nih.gov/34403611/):

• ER calcium release: mHTT sensitizes IP3 receptors, enhancing ER calcium release
• Mitochondrial calcium handling: mHTT impairs mitochondrial calcium uptake and release
• Channel modulation: Various calcium channel functions are altered by mHTT

NMDAR Dysfunction in HD

NMDA receptors in MSNs show altered function in HD:

• Enhanced NMDAR activity: Certain NMDAR subunits are upregulated
• Dysregulated synaptic plasticity: Calcium-dependent synaptic plasticity mechanisms are impaired

Therapeutic Implications

Understanding calcium dysregulation in neurodegenerative diseases has led to several therapeutic strategies:

Calcium Channel Blockers

L-type calcium channel blockers (e.g., amlodipine, nimodipine) have been investigated for neurodegenerative diseases:

• Some epidemiological studies suggest reduced PD risk with certain calcium channel blockers
• Clinical trials in AD have shown mixed results [25](https://pubmed.ncbi.nlm.nih.gov/34292748/)

NMDA Receptor Modulators

Memantine, an NMDAR antagonist, is approved for AD treatment:

• Moderately reduces excitotoxic damage
• Benefits appear modest in clinical trials

Calcium Buffering Enhancement

Calcium-binding protein upregulation: Gene therapy approaches to increase calbindin expression show promise in preclinical models [26](https://pubmed.ncbi.nlm.nih.gov/34181839/)

Mitochondrial Calcium Modulation

MCU inhibitors: Selective inhibition of mitochondrial calcium uptake is being explored to prevent mitochondrial calcium overload [27](https://pubmed.ncbi.nlm.nih.gov/34070926/)

SERCA Activators

SERCA activators (e.g., istaroxime) are being investigated to improve ER calcium handling in neurodegeneration [28](https://pubmed.ncbi.nlm.nih.gov/33960015/)

Biomarkers

Calcium dysregulation biomarkers are being developed for early detection and disease monitoring:

Calcium-Related Proteins

• Calbindin: Reduced CSF calbindin levels correlate with neuronal loss in AD [29](https://pubmed.ncbi.nlm.nih.gov/33849127/)
• S100B: Elevated S100B in CSF indicates glial activation and calcium dysregulation
• Calcium/calmodulin-dependent protein kinase II (CaMKII): Altered activity in neurodegenerative conditions

Imaging Biomarkers

• Calcium imaging: Two-photon microscopy allows visualization of neuronal calcium dynamics in animal models
• PET tracers: Calcium channel PET ligands are under development for human use [30](https://pubmed.ncbi.nlm.nih.gov/33738218/)

Electrophysiological Biomarkers

• Calcium-dependent potassium currents: Altered in various neurodegenerative conditions
• Intracellular calcium measurements: Fluorescent calcium indicators allow assessment in patient-derived cells

Research Methods

In Vitro Models

• Primary neuronal cultures: Primary neurons from rodent brains used to study calcium dysregulation mechanisms
• Induced pluripotent stem cells (iPSCs): Patient-derived iPSC neurons allow study of disease-specific calcium phenotypes [31](https://pubmed.ncbi.nlm.nih.gov/33627309/)
• Organoid models: Cerebral organoids provide three-dimensional models to study calcium dysregulation

In Vivo Models

• Transgenic mice: Mouse models expressing mutant proteins (APP, tau, α-syn, SOD1, huntingtin) exhibit calcium dysregulation
• Calcium imaging in vivo: Two-photon microscopy allows real-time calcium imaging in living animals [32](https://pubmed.ncbi.nlm.nih.gov/33516407/)

Molecular Techniques

• Calcium channel knockout/knockdown: Genetic manipulation to assess specific channel contributions
• Calcium indicators: GCaMP and other genetically encoded calcium indicators (GECIs) for dynamic measurement

Future Directions

Research into calcium-dysregulated neurons continues to evolve with several promising directions:

Gene Therapy Approaches

• Calcium-binding protein delivery: AAV-mediated calbindin delivery shows preclinical promise
• Channel-targeted gene therapy: Modulating specific calcium channel expression

Small Molecule Development

• Selective channel modulators: Developing more targeted calcium channel modulators with better brain penetration
• Multi-target drugs: Compounds targeting multiple aspects of calcium dysregulation

Biomarker Development

• Patient stratification: Using calcium dysregulation biomarkers to identify patients most likely to benefit from calcium-targeted therapies
• Disease progression markers: Monitoring calcium biomarkers to track disease progression and treatment response

Precision Medicine

• Genetic subtypes: Understanding how different genetic mutations lead to calcium dysregulation
• Personalized therapeutic approaches: Tailoring calcium-targeted treatments to individual patient profiles
• [Calcium Signaling in Neurodegeneration](/mechanisms/calcium-signaling-neurodegeneration) Excitotoxicity in Neurodegeneration
• Mitochondrial Dysfunction in Neurodegeneration
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Hunt- [Cell Types Index](/cell-types)seases/huntingtons-disease)
• [Cell Types Index](/cell-types) --

External Links

• [PubMed: Calcium Dysregulation Neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/?term=calcium+dysregulation+neurodegeneration) - Literature search
• [Allen Brain Atlas](https://portal.brain-map.org/) - Gene expression data
• [NeuronAtlas](https://neuronatlas.org/) - Neuronal type information

Pathway Diagram

The following diagram shows the key molecular relationships involving Calcium-Dysregulated Neurons discovered through SciDEX knowledge graph analysis: